Gene | Gene Full Name | DSI g | DPI g | pLI | Disease | Type | Score gda | EL gda | EI gda | N. PMIDs | N. SNPs gda | First Ref. | Last Ref. | ||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
long intergenic non-protein coding RNA 1194 | 0.470 | 0.769 |
|
group | 0.100 | None | 1.000 | 63 | 0 | 1975 | 2020 | |||||||||
|
ABO, alpha 1-3-N-acetylgalactosaminyltransferase and alpha 1-3-galactosyltransferase | 0.427 | 0.885 |
|
group | 0.100 | None | 0.882 | 17 | 2 | 1975 | 2019 | |||||||||
|
cytochrome c oxidase subunit 8A | 0.400 | 0.846 | 0.12 |
|
group | 0.100 | None | 1.000 | 15 | 0 | 1977 | 2019 | ||||||||
|
glucose-6-phosphate dehydrogenase | 0.424 | 0.846 | 0.97 |
|
group | 0.100 | None | 0.857 | 14 | 2 | 1977 | 2019 | ||||||||
|
PKHD1 ciliary IPT domain containing fibrocystin/polyductin | 0.576 | 0.654 | 1.2E-47 |
|
group | 0.020 | None | 1.000 | 2 | 0 | 1977 | 2017 | ||||||||
|
CEA cell adhesion molecule 5 | 0.420 | 0.846 | 4.2E-10 |
|
group | 0.100 | None | 0.967 | 150 | 0 | 1978 | 2020 | ||||||||
|
colony stimulating factor 2 | 0.330 | 0.962 | 0.83 |
|
group | 0.100 | None | 0.950 | 40 | 0 | 1978 | 2019 | ||||||||
|
major histocompatibility complex, class II, DR beta 5 | 0.608 | 0.731 | 3.6E-07 |
|
group | 0.010 | None | 1.000 | 1 | 0 | 1978 | 1978 | ||||||||
|
cytochrome P450 family 1 subfamily A member 1 | 0.436 | 0.846 | 1.1E-17 |
|
group | 0.100 | None | 0.941 | 85 | 3 | 1979 | 2019 | ||||||||
|
cytochrome P450 family 1 subfamily B member 1 | 0.457 | 0.769 | 2.2E-05 |
|
group | 0.100 | None | 0.973 | 37 | 8 | 1979 | 2020 | ||||||||
|
cytochrome P450 family 1 subfamily A member 2 | 0.494 | 0.923 | 2.5E-10 |
|
group | 0.100 | None | 0.941 | 17 | 1 | 1979 | 2020 | ||||||||
|
cytochrome P450 family 3 subfamily A member 5 | 0.511 | 0.846 | 6.3E-17 |
|
group | 0.100 | None | 0.941 | 17 | 1 | 1979 | 2018 | ||||||||
|
cytochrome P450 family 3 subfamily A member 7 | 0.670 | 0.500 | 6.1E-14 |
|
group | 0.030 | None | 1.000 | 3 | 0 | 1979 | 2019 | ||||||||
|
CYP3A7-CYP3A51P readthrough | 0.821 | 0.154 |
|
group | 0.020 | None | 1.000 | 2 | 0 | 1979 | 1979 | |||||||||
|
amine oxidase copper containing 1 | 0.628 | 0.769 | 6.7E-08 |
|
group | 0.020 | None | 1.000 | 2 | 0 | 1979 | 2018 | ||||||||
|
BCR activator of RhoGEF and GTPase | 0.431 | 0.885 | 0.99 |
|
group | 0.100 | None | 0.971 | 34 | 0 | 1980 | 2019 | ||||||||
|
alpha fetoprotein | 0.429 | 0.885 | 1.1E-11 |
|
group | 0.100 | None | 1.000 | 55 | 0 | 1981 | 2020 | ||||||||
|
arylsulfatase B | 0.595 | 0.692 | 7.0E-09 |
|
group | 0.020 | None | 1.000 | 2 | 0 | 1981 | 2016 | ||||||||
|
plasminogen activator, tissue type | 0.445 | 0.885 | 5.7E-05 |
|
group | 0.090 | None | 1.000 | 9 | 0 | 1982 | 2019 | ||||||||
|
BMS1 pseudogene 20 | 0.682 | 0.577 |
|
group | 0.010 | None | 1.000 | 1 | 0 | 1982 | 1982 | |||||||||
|
HRas proto-oncogene, GTPase | 0.378 | 0.885 | 8.0E-02 |
|
group | 0.100 | None | 0.958 | 71 | 6 | 1983 | 2019 | ||||||||
|
CEA cell adhesion molecule 3 | 0.494 | 0.731 | 1.1E-09 |
|
group | 0.100 | None | 0.968 | 31 | 0 | 1983 | 2019 | ||||||||
|
CEA cell adhesion molecule 7 | 0.494 | 0.769 | 1.3E-07 |
|
group | 0.100 | None | 0.967 | 30 | 0 | 1983 | 2019 | ||||||||
|
pregnancy specific beta-1-glycoprotein 2 | 0.492 | 0.731 | 1.4E-30 |
|
group | 0.100 | None | 0.967 | 30 | 0 | 1983 | 2019 | ||||||||
|
major histocompatibility complex, class I, A | 0.370 | 0.846 | 1.3E-03 |
|
group | 0.100 | None | 0.913 | 23 | 2 | 1983 | 2019 |